AutoML-Driven Insights into Patient Outcomes and Emergency Care During Romania’s First Wave of COVID-19.

AutoML-Driven Insights into Patient Outcomes and Emergency Care During Romania’s First Wave of COVID-19.

Publication date: Dec 15, 2024

The COVID-19 pandemic severely impacted healthcare systems, affecting patient outcomes and resource allocation. This study applied automated machine learning (AutoML) to analyze key health outputs, such as discharge conditions, mortality, and COVID-19 cases, with the goal of improving responses to future crises. AutoML was used to train and validate models on an ICD-10 dataset covering the first wave of COVID-19 in Romania (January-September 2020). For discharge outcomes, Light Gradient Boosted models achieved an F1 score of 0. 9644, while for mortality 0. 7545 was reached. A Generalized Linear Model blender achieved an F1 score of 0. 9884 for “acute or emergency” cases, and an average blender reached 0. 923 for COVID-19 cases. Older age, specific hospitals, and oncology wards were less associated with improved recovery rates, while mortality was linked to abnormal lab results and cardiovascular/respiratory diseases. Patients admitted without referral, or patients in hospitals in the central region and the capital region of Romania were more likely to be acute cases. Finally, counties such as Argeş (South-Muntenia) and Brașov (Center) showed higher COVID-19 infection rates regardless of age. AutoML provided valuable insights into patient outcomes, highlighting variations in care and the need for targeted health strategies for both COVID-19 and other health challenges.

Open Access PDF

Concepts Keywords
Blender artificial intelligence
Hospitals automated machine learning
Pandemic COVID-19
Train disease prediction

Semantics

Type Source Name
disease MESH Emergency
disease MESH COVID-19
drug DRUGBANK Flunarizine
disease MESH respiratory diseases
disease MESH infection
drug DRUGBANK Coenzyme M
disease MESH syndrome
disease IDO country
disease IDO process
disease IDO quality
disease IDO intervention
disease MESH tics
disease MESH psoriasis
disease MESH eczema
disease MESH psoriatic arthritis
disease MESH parasitic diseases
disease MESH mania
disease MESH education level
drug DRUGBANK Isoxaflutole
drug DRUGBANK Saquinavir
drug DRUGBANK MCC
disease MESH cardiac arrest
disease MESH respiratory failure
disease MESH death
disease MESH infectious diseases
disease MESH morbidities
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH chronic conditions
disease MESH complications
drug DRUGBANK Oxygen
disease MESH hypertension
disease MESH privacy
drug DRUGBANK Ceftazidime
disease IDO algorithm
disease MESH community transmission
disease MESH ascariasis
disease MESH enterobiasis
disease MESH cystic echinococcosis
drug DRUGBANK Trestolone
drug DRUGBANK Ranitidine
drug DRUGBANK Guanosine
disease MESH Fatal Outcomes
disease MESH COPD
drug DRUGBANK Efavirenz
disease MESH Hernia
disease MESH Myocardial Infarction
disease MESH comorbidity

Original Article

(Visited 1 times, 1 visits today)